We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$11.9B
AUM Growth
+$1.4B
(+13%)
Cap. Flow
+$748M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$134M |
| 2 |
STMicroelectronics
STM
|
+$103M |
| 3 |
Meta Platforms (Facebook)
META
|
+$89.9M |
| 4 |
MetLife
MET
|
+$71.9M |
| 5 |
Gilead Sciences
GILD
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$161M |
| 2 |
Eli Lilly
LLY
|
+$153M |
| 3 |
MRSH
Marsh
MRSH
|
+$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$91.8M |
| 5 |
Electronic Arts
EA
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.43% |
| 2 | Technology | 17.4% |
| 3 | Industrials | 8.07% |
| 4 | Energy | 6.4% |
| 5 | Financials | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRDN
301
Guardian Pharmacy Services
GRDN
$2.56B
| $9.54M | 0.08% |
+568,131
| New | +$9.57M |
|
302
Cognizant
CTSH
$25.1B
| $9.53M | 0.08% |
123,440
-274,276
| -69% | -$20.4M |
|
303
Badger Meter
BMI
$4.04B
| $9.42M | 0.08% |
+43,119
| New | +$8.64M |
|
304
Lantheus
LNTH
$6.63B
| $9.4M | 0.08% |
85,678
+1,678
| +2% | +$174K |
|
305
Airbnb
ABNB
$90.5B
| $9.38M | 0.08% |
73,939
-130,665
| -64% | -$16.9M |
|
306
Sigma Lithium
SGML
$1.18B
| $9.37M | 0.08% |
+757,749
| New | +$8.27M |
|
307
A.O. Smith
AOS
$8.59B
| $9.36M | 0.08% |
+104,240
| New | +$8.63M |
|
308
Seagate
STX
$190B
| $9.35M | 0.08% |
85,336
-212,986
| -71% | -$21.8M |
|
309
ANI Pharmaceuticals
ANIP
$1.8B
| $9.34M | 0.08% |
+156,488
| New | +$9.55M |
|
310
Jasper Therapeutics
JSPR
$22M
| $9.31M | 0.08% |
495,104
+81,164
| +20% | +$1.62M |
|
311
COPT Defense Properties
CDP
$4.24B
| $9.3M | 0.08% |
+306,672
| New | +$8.73M |
|
312
e.l.f. Beauty
ELF
$5.09B
| $9.3M | 0.08% |
85,270
+53,450
| +168% | +$8.39M |
|
|
ACLX
313
DELISTED
Arcellx
ACLX
| $9.27M | 0.08% |
110,989
+3,290
| +3% | +$219K |
|
314
Lifestance Health
LFST
$3.96B
| $9.26M | 0.08% |
+1,323,390
| New | +$7.95M |
|
315
Old Dominion Freight Line
ODFL
$44.8B
| $9.26M | 0.08% |
+46,613
| New | +$9.07M |
|
316
Restaurant Brands International
QSR
$25.8B
| $9.22M | 0.08% |
127,779
-586,585
| -82% | -$41.2M |
|
317
Coursera
COUR
$1.66B
| $9.08M | 0.08% |
+1,143,841
| New | +$9.04M |
|
318
Watsco Inc
WSO
$13.7B
| $9.06M | 0.08% |
+18,417
| New | +$8.85M |
|
319
International Paper
IP
$22.4B
| $8.91M | 0.08% |
+182,316
| New | +$8.49M |
|
320
Moderna
MRNA
$22.5B
| $8.79M | 0.07% |
+131,555
| New | +$12.1M |
|
321
Petco
WOOF
$834M
| $8.76M | 0.07% |
+1,924,297
| New | +$6.53M |
|
322
CDW
CDW
$17.9B
| $8.73M | 0.07% |
+38,558
| New | +$8.56M |
|
323
Ocular Therapeutix
OCUL
$1.87B
| $8.7M | 0.07% |
+1,000,000
| New | +$8.24M |
|
|
DVAX
324
DELISTED
Dynavax Technologies
DVAX
| $8.66M | 0.07% |
777,319
-228,708
| -23% | -$2.52M |
|
325
Immunocore
IMCR
$1.69B
| $8.55M | 0.07% |
274,681
+643
| +0.2% | +$23.4K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.
- Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
- Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
- Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
- Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
- Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
- Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
- Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.
Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.